Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Diabetic patients account for an increasing number of patients undergoing percutaneous coronary intervention (PCI). However, diabetes mellitus (DM) is associated with increased residual platelet activity during dual antiplatelet treatment (DAPT) and DM patients have worse clinical outcomes after PCI as compared to non-DM.

Source: Progress in Cardiovascular Diseases - December 22, 2017 Category: Cardiology Authors: Abhishek Sharma, Aakash Garg, Sammy Elmariah, Douglas Drachman, Chukwudi Obiagwu, Ajay Vallakati, Samin K. Sharma, Carl J. Lavie, Debabrata Mukherjee, Ron Waksman, Giulio G. Stefanini, Fausto Feres, Jonathan D. Marmur, G érard Helft Source Type: research